REHOVOT, Israel, March 28,
2024 /PRNewswire/ -- Evogene Ltd. (Nasdaq: EVGN)
(TASE: EVGN), a leading computational biology company targeting to
revolutionize life-science-based product discovery and development
utilizing cutting edge computational biology technologies, across
multiple market segments, today announced that it filed its Annual
Report on Form 20-F for the fiscal year ended December 31, 2023, with the Securities and
Exchange Commission.
The Annual Report on Form 20-F can be accessed on the Company's
investor relations website https://evogene.com/investor-relations/
and on the SEC's website at http://www.sec.gov. The Company's
security holders may request a hard copy of the Annual Report free
of charge by visiting the Contact Us page of the Company's
website.
About Evogene:
Evogene Ltd. (Nasdaq: EVGN, TASE: EVGN) is a computational
biology company leveraging big data and artificial
intelligence, aiming to revolutionize the development of
life-science-based products by utilizing cutting-edge technologies
to increase the probability of success while reducing development
time and cost.
Evogene established three unique tech-engines -
MicroBoost AI, ChemPass
AI and GeneRator AI. Each
tech-engine is focused on the discovery and development of
products based on one of the following core components: microbes
(MicroBoost AI), small molecules (ChemPass AI), and
genetic elements (GeneRator AI).
Evogene uses its tech-engines to develop products through
strategic partnerships and collaborations, and its five
subsidiaries including:
1. Biomica Ltd.
(www.biomicamed.com) developing and advancing novel
microbiome-based therapeutics to treat human disorders powered
by MicroBoost AI;
2. Lavie Bio
Ltd. (www.lavie-bio.com) - developing and
commercially advancing, microbiome based ag-biologicals powered
by MicroBoost AI;
3. AgPlenus Ltd. (www.agplenus.com) -developing
next generation ag chemicals for effective and sustainable crop
protection powered by ChemPass AI;
4. Canonic
Ltd. (www.canonicbio.com) – developing medical
cannabis products based on decoding plant genetics for optimized
therapeutic effect powered by GeneRator AI;
and
5. Casterra Ag Ltd. (www.casterra.co)–
developing and marketing superior castor seed varieties producing
high yield and high-grade oil content, on an industrial scale for
the biofuel and other industries powered by GeneRator
AI.
For more information, please visit: www.evogene.com.
Contact
Rachel Pomerantz Gerber
Head of Investor Relations at Evogene
rachel.pomerantz@evogene.com
Tel: +972-8-9311901
Logo -
https://mma.prnewswire.com/media/1947468/Evogene_Logo.jpg
View original
content:https://www.prnewswire.com/news-releases/evogene-announces-filing-of-annual-report-on-form-20-f-302102466.html
SOURCE Evogene
